95.46
-0.86
(-0.89%)
At close: January 10 at 5:35:43 PM GMT+1
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
--
10,258,000.00
10,526,000.00
10,522,000.00
7,418,000.00
Investing Cash Flow
--
-6,200,000.00
-2,075,000.00
-7,298,000.00
3,619,000.00
Financing Cash Flow
--
-8,052,000.00
-5,821,000.00
-7,056,000.00
-6,485,000.00
End Cash Position
--
8,710,000.00
12,736,000.00
10,098,000.00
13,915,000.00
Income Tax Paid Supplemental Data
--
2,623,000.00
2,452,000.00
1,280,000.00
2,051,000.00
Interest Paid Supplemental Data
--
559,000.00
380,000.00
334,000.00
315,000.00
Capital Expenditure
--
-3,024,000.00
-2,201,000.00
-2,043,000.00
-2,083,000.00
Issuance of Capital Stock
--
195,000.00
188,000.00
186,000.00
203,000.00
Issuance of Debt
--
48,000.00
1,549,000.00
--
2,019,000.00
Repayment of Debt
--
-3,949,000.00
-3,009,000.00
-2,390,000.00
-4,186,000.00
Repurchase of Capital Stock
--
-593,000.00
-497,000.00
-382,000.00
-822,000.00
Free Cash Flow
--
7,234,000.00
8,325,000.00
8,479,000.00
5,335,000.00
12/31/2020 - 12/28/2007
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
0R1F.IL Bristol-Myers Squibb Company
56.55
-0.19%
IDP.DE Biogen Inc.
144.80
-0.34%
C43.DE Cosmo Pharmaceuticals N.V.
69.00
+0.73%
GS71.DE GSK plc
16.24
-0.18%
GIS.DE Gilead Sciences, Inc.
87.37
+1.35%
6MK.DE Merck & Co., Inc.
97.70
+0.51%
ZEG.F AstraZeneca PLC
131.35
-0.61%
BRM.DE Bristol-Myers Squibb Company
54.92
+0.02%
4AB.DE AbbVie Inc.
172.44
+0.44%
ZEG.DE AstraZeneca PLC
131.25
+0.04%